These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 34295236)
1. Corrigendum: Dl-3- Chen Y; Wu T; Li H; Li X; Li Q; Zhu X; Yu M; Kuo SH; Huang F; Wu YC Front Aging Neurosci; 2021; 13():620015. PubMed ID: 34295236 [TBL] [Abstract][Full Text] [Related]
2. Dl-3- Chen Y; Wu T; Li H; Li X; Li Q; Zhu X; Yu M; Kuo SH; Huang F; Wu YC Front Aging Neurosci; 2019; 11():44. PubMed ID: 30873019 [TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice. Chang Y; Yao Y; Ma R; Wang Z; Hu J; Wu Y; Jiang X; Li L; Li G Front Neurosci; 2021; 15():716049. PubMed ID: 34248497 [TBL] [Abstract][Full Text] [Related]
4. Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson's Disease. Gan P; Ding L; Hang G; Xia Q; Huang Z; Ye X; Qian X Front Pharmacol; 2020; 11():776. PubMed ID: 32528295 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models. Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of cathepsin D protects dopaminergic neurons against neuroinflammation-mediated neurotoxicity through inhibition of NF-κB signalling pathway in Parkinson's disease model. Gan P; Xia Q; Hang G; Zhou Y; Qian X; Wang X; Ding L Clin Exp Pharmacol Physiol; 2019 Apr; 46(4):337-349. PubMed ID: 30485484 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation. Yang L; Zhou R; Tong Y; Chen P; Shen Y; Miao S; Liu X Neurobiol Dis; 2020 Jul; 140():104814. PubMed ID: 32087283 [TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA-Analysis From a Nationwide, Multicenter Registry. Tan Z; Zhao Y; Yang W; He S; Ding Y; Xu A Front Neurol; 2021; 12():800494. PubMed ID: 34899589 [TBL] [Abstract][Full Text] [Related]
9. Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation-induced cell death. Liu TY; Yang XY; Zheng LT; Wang GH; Zhen XC J Neurochem; 2017 Feb; 140(4):589-604. PubMed ID: 27889907 [TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease. Shim KH; Go HG; Bae H; Jeong DE; Kim D; Youn YC; Kim S; An SSA; Kang MJ Front Aging Neurosci; 2021; 13():726525. PubMed ID: 34305578 [TBL] [Abstract][Full Text] [Related]
11. Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination. Wu Y; Dong L; Huang Q; Sun L; Liao Y; Tang Y; Wu Y Life Sci; 2019 Sep; 232():116501. PubMed ID: 31163175 [TBL] [Abstract][Full Text] [Related]
12. Calycosin attenuates MPTP-induced Parkinson's disease by suppressing the activation of TLR/NF-κB and MAPK pathways. Yang J; Jia M; Zhang X; Wang P Phytother Res; 2019 Feb; 33(2):309-318. PubMed ID: 30421460 [TBL] [Abstract][Full Text] [Related]
13. Corrigendum: A progression analysis of motor features in Parkinson's disease based on the mapper algorithm. Ma LY; Feng T; He C; Li M; Ren K; Tu J Front Aging Neurosci; 2023; 15():1174022. PubMed ID: 37077502 [TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Experimental Models of Cognitive Impairment for Use in Parkinson's Disease Research: The Distance Between Reality and Ideal. Fan Y; Han J; Zhao L; Wu C; Wu P; Huang Z; Hao X; Ji Y; Chen D; Zhu M Front Aging Neurosci; 2021; 13():827753. PubMed ID: 35002685 [TBL] [Abstract][Full Text] [Related]
15. Corrigendum: CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson's disease. Wang R; Tong S; Wang M; Zou J; Wang N; Sun F; Zhou X; Chen J; Wang H Front Aging Neurosci; 2023; 15():1250440. PubMed ID: 37600516 [TBL] [Abstract][Full Text] [Related]
16. Dl-3-n-butylphthalide attenuates acute inflammatory activation in rats with spinal cord injury by inhibiting microglial TLR4/NF-κB signalling. He Z; Zhou Y; Lin L; Wang Q; Khor S; Mao Y; Li J; Zhen Z; Chen J; Gao Z; Wu F; Zhang X; Zhang H; Xu HZ; Wang Z; Xiao J J Cell Mol Med; 2017 Nov; 21(11):3010-3022. PubMed ID: 28842949 [TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Detection of Microbial 16S rRNA Gene in the Blood of Patients With Parkinson's Disease. Qian Y; Yang X; Xu S; Wu C; Qin N; Chen SD; Xiao Q Front Aging Neurosci; 2019; 11():4. PubMed ID: 30760995 [TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Cortical gyrification pattern of depression in Parkinson's disease: a neuroimaging marker for disease severity? Shen Q; Liao H; Cai S; Liu Q; Wang M; Song C; Zhou F; Liu Y; Yuan J; Tang Y; Li X; Liu J; Tan C Front Aging Neurosci; 2024; 16():1428166. PubMed ID: 38872628 [TBL] [Abstract][Full Text] [Related]
19. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways. Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366 [TBL] [Abstract][Full Text] [Related]
20. Dl-butylphthalide inhibits rotenone-induced oxidative stress in microglia via regulation of the Keap1/Nrf2/HO-1 signaling pathway. Luo R; Zhu L; Zeng Z; Zhou R; Zhang J; Xiao S; Bi W Exp Ther Med; 2021 Jun; 21(6):597. PubMed ID: 33884035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]